NDC 59267-1055

Pfizer-BioNTech Covid-19 Vaccine

Bnt162b2

Pfizer-BioNTech Covid-19 Vaccine is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Pfizer Manufacturing Belgium Nv. The primary component is Tozinameran.

• Product ID: 59267-1055_073f91e1-999c-4e03-a3fa-17fe941f2313
• NDC: 59267-1055
• Product Type: Vaccine
• Proprietary Name: Pfizer-BioNTech Covid-19 Vaccine
• Generic Name: Bnt162b2
• Dosage Form: Injection, Suspension
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2021-10-30
• Marketing Category: EMERGENCY USE AUTHORIZATION /
• Labeler Name: Pfizer Manufacturing Belgium NV
• Substance Name: TOZINAMERAN
• Active Ingredient Strength: 130 ug/2.6mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 59267-1055-4

10 VIAL, GLASS in 1 CARTON (59267-1055-4) > 2.6 mL in 1 VIAL, GLASS (59267-1055-1)

• Marketing Start Date: 2021-10-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Pfizer-BioNTech Covid-19 Vaccine" or generic name "Bnt162b2"

NDC	Brand Name	Generic Name
59267-0078	Pfizer-BioNTech Covid-19 Vaccine	BNT162b2
59267-1000	Pfizer-BioNTech Covid-19 Vaccine	RNA ingredient BNT-162B2
59267-1025	Pfizer-BioNTech Covid-19 Vaccine	BNT162b2